MedPath

Five Eleven Pharma, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Employees
-
Market Cap
-
Website

PSMA-PET to Guide Prostatectomy

Phase 2
Recruiting
Conditions
Prostate Cancer
Interventions
Diagnostic Test: PSMA-PET and SOC MRI
Diagnostic Test: SOC MRI
First Posted Date
2022-05-19
Last Posted Date
2025-01-31
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
288
Registration Number
NCT05381103
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, United States

Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers

Phase 1
Completed
Conditions
Alzheimer Disease
Interventions
First Posted Date
2019-04-04
Last Posted Date
2021-07-20
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
14
Registration Number
NCT03902548
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers

Phase 1
Completed
Conditions
Parkinson Disease
Interventions
First Posted Date
2019-04-04
Last Posted Date
2023-01-11
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
4
Registration Number
NCT03903549
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Phase 1
Active, not recruiting
Conditions
Prostate Cancer Recurrent
Prostate Cancer
Interventions
First Posted Date
2018-02-23
Last Posted Date
2022-05-02
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
60
Registration Number
NCT03444844
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, United States

Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Renal Cancer
Interventions
First Posted Date
2017-03-08
Last Posted Date
2025-02-26
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
30
Registration Number
NCT03073395
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

Early Phase 1
Completed
Conditions
Prostate Cancer
Bone Metastases
Interventions
First Posted Date
2016-07-11
Last Posted Date
2023-01-12
Lead Sponsor
Five Eleven Pharma, Inc.
Target Recruit Count
14
Registration Number
NCT02826382
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Pennsylvania, Philadelphia, Pennsylvania, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath